BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 86 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q1 2022. The put-call ratio across all filers is 15.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $137,964 | -97.9% | 48,071 | -96.4% | 0.00% | -100.0% |
| Q2 2023 | $6,713,511 | +527.4% | 1,329,408 | +134.8% | 0.00% | – |
| Q1 2023 | $1,070,063 | -26.9% | 566,171 | -30.4% | 0.00% | – |
| Q4 2022 | $1,464,296 | +393.0% | 813,498 | +364.5% | 0.00% | – |
| Q3 2022 | $297,000 | -26.7% | 175,149 | +6.2% | 0.00% | – |
| Q2 2022 | $405,000 | +127.5% | 164,944 | +155.8% | 0.00% | – |
| Q1 2022 | $178,000 | -45.6% | 64,488 | +5.2% | 0.00% | – |
| Q4 2021 | $327,000 | -59.8% | 61,297 | -36.2% | 0.00% | – |
| Q3 2021 | $813,000 | -37.0% | 96,126 | -9.2% | 0.00% | – |
| Q2 2021 | $1,291,000 | +60.8% | 105,881 | +219.7% | 0.00% | – |
| Q1 2021 | $803,000 | – | 33,119 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,449,845 | $5,830,000 | 0.29% |
| K2 PRINCIPAL FUND, L.P. | 1,031,511 | $1,743,000 | 0.20% |
| Boxer Capital, LLC | 2,014,858 | $3,405,000 | 0.19% |
| DAFNA Capital Management LLC | 313,600 | $530,000 | 0.14% |
| Newtyn Management, LLC | 350,000 | $592,000 | 0.13% |
| Artal Group S.A. | 1,646,517 | $2,783,000 | 0.12% |
| Bellevue Group AG | 4,717,113 | $7,972,000 | 0.11% |
| MPM BioImpact LLC | 239,888 | $405,000 | 0.10% |
| RA Capital Management | 2,589,904 | $4,377,000 | 0.09% |
| Beacon Capital Management, LLC | 35,615 | $88,000 | 0.03% |